ABCG2 | ATP-binding cassette, sub-family G (WHITE), member 2 | Cancer-related genes CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
ACE2 | Angiotensin I converting enzyme 2 | Enzymes FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
ACY3 | Aspartoacylase (aminocyclase) 3 | Enzymes
| | | | | Tissue enhanced |
AGR3 | Anterior gradient 3 | Predicted secreted proteins
| | | | | Tissue enhanced |
AKR1B10 | Aldo-keto reductase family 1, member B10 (aldose reductase) | | | | | | Tissue enhanced |
ANXA13 | Annexin A13 | Plasma proteins
| | | | | Tissue enhanced |
B3GALT5 | UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5 | Predicted secreted proteins
| | | | | Tissue enhanced |
C1orf106 | Chromosome 1 open reading frame 106 | | | | | | Tissue enhanced |
CDHR5 | Cadherin-related family member 5 | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CLDN3 | Claudin 3 | Cancer-related genes Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
CYP4F12 | Cytochrome P450, family 4, subfamily F, polypeptide 12 | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
DAB1 | Dab, reelin signal transducer, homolog 1 (Drosophila) | | | | | | Tissue enhanced |
DDC | Dopa decarboxylase (aromatic L-amino acid decarboxylase) | Disease related genes Enzymes FDA approved drug targets
| | | | | Tissue enhanced |
DPEP1 | Dipeptidase 1 (renal) | Enzymes FDA approved drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
DPP4 | Dipeptidyl-peptidase 4 | CD markers Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
EPCAM | Epithelial cell adhesion molecule | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
FAM211A | Family with sequence similarity 211, member A | | | | | | Tissue enhanced |
GCNT3 | Glucosaminyl (N-acetyl) transferase 3, mucin type | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
GDA | Guanine deaminase | Enzymes Plasma proteins
| | | | | Tissue enhanced |
GNG13 | Guanine nucleotide binding protein (G protein), gamma 13 | RAS pathway related proteins
| | | | | Tissue enhanced |
HNF1A | HNF1 homeobox A | Cancer-related genes Disease related genes Transcription factors
| | | | | Tissue enhanced |
HNF4A | Hepatocyte nuclear factor 4, alpha | Disease related genes Nuclear receptors Transcription factors
| | | | | Tissue enhanced |
HRASLS2 | HRAS-like suppressor 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
LGALS4 | Lectin, galactoside-binding, soluble, 4 | Cancer-related genes Plasma proteins
| | | | | Tissue enhanced |
MIA2 | Melanoma inhibitory activity 2 | Predicted secreted proteins
| | | | | Tissue enhanced |
MISP | Mitotic spindle positioning | Cytoskeleton related proteins
| | | | | Tissue enhanced |
MME | Membrane metallo-endopeptidase | Cancer-related genes Candidate cardiovascular disease genes CD markers Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
MYO7B | Myosin VIIB | Cytoskeleton related proteins
| | | | | Tissue enhanced |
PLS1 | Plastin 1 | | | | | | Tissue enhanced |
PRODH | Proline dehydrogenase (oxidase) 1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Tissue enhanced |
PRR15 | Proline rich 15 | | | | | | Tissue enhanced |
REG1B | Regenerating islet-derived 1 beta | Predicted secreted proteins
| | | | | Tissue enhanced |
RNF186 | Ring finger protein 186 | Predicted membrane proteins
| | | | | Tissue enhanced |
RP11-1220K2.2 | Putative inactive maltase-glucoamylase-like protein LOC93432 | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
RP11-407N17.3 | CTAGE family member 5 isoform 4 | Predicted membrane proteins
| | | | | Tissue enhanced |
SCIN | Scinderin | Cytoskeleton related proteins Plasma proteins
| | | | | Tissue enhanced |
SECTM1 | Secreted and transmembrane 1 | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
SLC23A1 | Solute carrier family 23 (ascorbic acid transporter), member 1 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC28A2 | Solute carrier family 28 (concentrative nucleoside transporter), member 2 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SOWAHA | Sosondowah ankyrin repeat domain family member A | Predicted secreted proteins
| | | | | Tissue enhanced |
TMC5 | Transmembrane channel-like 5 | Predicted membrane proteins
| | | | | Tissue enhanced |
TMEM45B | Transmembrane protein 45B | Predicted membrane proteins
| | | | | Tissue enhanced |
TRPM5 | Transient receptor potential cation channel, subfamily M, member 5 | Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
TSPAN8 | Tetraspanin 8 | Cancer-related genes Predicted membrane proteins
| | | | | Tissue enhanced |
VDR | Vitamin D (1,25- dihydroxyvitamin D3) receptor | Disease related genes FDA approved drug targets Nuclear receptors Transcription factors
| | | | | Tissue enhanced |
ZNF488 | Zinc finger protein 488 | Predicted secreted proteins
| | | | | Tissue enhanced |